First Mercantile Trust’s Ionis Pharmaceuticals IONS Stock Holding History

First Mercantile Trust’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,000	Closed	-$58K	–	982
2015 Q2	$58K	Sell	1,000 -6,544	-87%	-$416K	0.01%	940
2015 Q1	$480K	Sell	7,544 -1,396	-16%	-$94.7K	0.04%	510
2014 Q4	$552K	Buy	8,940 +7,180	+408%	+$354K	0.05%	476
2014 Q3	$68K	Buy	+1,760	New	+$62.4K	0.01%	959
2014 Q2	–	Sell	-21,252	Closed	-$919K	–	1234
2014 Q1	$919K	Buy	21,252 +8,577	+68%	+$416K	0.07%	398
2013 Q4	$505K	Sell	12,675 -3,280	-21%	-$117K	0.04%	559
2013 Q3	$599K	Buy	+15,955	New	+$477K	0.05%	519

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

First Mercantile Trust's IONS Position: Q3 2015 in Review

First Mercantile Trust sold out of Ionis Pharmaceuticals (IONS) in Q3 2015, closing a stake of 1,000 shares — an estimated $58K sold.

First Mercantile Trust first reported a position in IONS in Q3 2013 and held it in 7 quarters. The position peaked at $919K in Q1 2014. 314 funds tracked by Wall St. Rank hold IONS as of Q3 2015.

First Mercantile Trust reported no remaining Ionis Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
First Mercantile Trust sold 1,000 Ionis Pharmaceuticals shares in Q3 2015, an estimated $58K.
First Mercantile Trust first reported a position in Ionis Pharmaceuticals in Q3 2013 and held it in 7 quarters.
First Mercantile Trust's Ionis Pharmaceuticals position peaked at $919K in Q1 2014.
314 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2015.

Based on First Mercantile Trust's 13F filing for Q3 2015, filed 13 Oct 2015.